ALPHINA THERAPEUTICS, INC.

Profile

Company Names

ALPHINA THERAPEUTICS, INC.

Addresses

55 CHURCH STREET, NEW HAVEN, CT 06510

36 CHURCH LANE, WESTPORT, CT 06880

Phone Numbers

(650) 438-8738
(203) 435-2255

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$17,005,305.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2026-02-23 
$153,715.00 
$10,000,000.00 
$9,846,285.00 
 
1
2021-09-07 
$16,851,590.00 
$39,999,997.00 
$23,148,407.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANURAG 
 
AGARWAL 
DIRECTOR
RISK MANAGEMENT SOLUTIONS, INC.   |  ALPHINA THERAPEUTICS, INC.
RANJIT 
 
BINDRA 
EXECUTIVE OFFICER, DIRECTOR
HELIX THERAPEUTICS, LLC   |  HELIX THERAPEUTICS, INC.   |  ALPHINA THERAPEUTICS, INC.   |  AZTEK BIO, INC.   |  MODIFI BIOSCIENCES, INC.   |  CAPEHAVEN HOLDING COMPANY, LLC
STANLEY 
 
CHOY 
EXECUTIVE OFFICER
KOLLTAN PHARMACEUTICALS INC   |  ALPHINA THERAPEUTICS, INC.
MATTHEW 
 
COHEN 
DIRECTOR
LATITUDE SOLUTIONS, INC.   |  TRIQ, INC.   |  IMPACT DIRECTLY PBC   |  NITROUS FUNDING LLC   |  INVEST FORWARD, INC.   |  SUREPORT HOLDINGS INC.   |  IMMVENTION THERAPEUTIX, INC.   |  TRUTAG TECHNOLOGIES, INC.   |  RIPPLE VENTURES 11-21 L.P. (WISEDOCS)   |  RIPPLE CAPITAL 02-21 L.P. (UDACITY)   |  RIPPLE VENTURES 11-19 L.P. (TREAD)   |  RIPPLE VENTURES SPECIAL OPPORTUNITIES FUND I LP   |  RIPPLE VENTURES 10-20 L.P. (ROSE ROCKET)   |  RIPPLE VENTURES 08-20 L.P. (ONCALL)   |  RIPPLE VENTURES FUND III LP   |  RIPPLE VENTURES FUND I, LP   |  OSAGE UNIVERSITY PARTNERS IV, LP   |  OUP IV AFF PARTNERSHIP, LP   |  TRANSAERA, INC.   |  ALPHINA THERAPEUTICS, INC.
COLLEEN 
 
CUFFARO 
EXECUTIVE OFFICER, DIRECTOR
ARRAKIS THERAPEUTICS, INC.   |  ALPHINA THERAPEUTICS, INC.
BARBARA 
 
FOX 
EXECUTIVE OFFICER, DIRECTOR
TILOS THERAPEUTICS, INC.   |  ALPHINA THERAPEUTICS, INC.
NICHOLAS 
J 
GALLI 
EXECUTIVE OFFICER, DIRECTOR
ALPHINA THERAPEUTICS, INC.
KEVIN 
 
RAKIN 
DIRECTOR
HELIX THERAPEUTICS, LLC   |  HELIX THERAPEUTICS, INC.   |  CYVEK, INC.   |  HISTOGENICS CORP   |  CHEETAH MEDICAL, INC.   |  HIGHCAPE PARTNERS QP, L.P.   |  HIGHCAPE PARTNERS, L.P.   |  TELA BIO, INC.   |  CYOMICS, LLC   |  AZIYO BIOLOGICS, INC.   |  CYBREXA HOLDING COMPANY, LLC   |  CONVEXITY SCIENTIFIC INC.   |  HIGHCAPE PARTNERS II, L.P.   |  HIGHCAPE PARTNERS QP II, L.P.   |  HIGHCAPE PARTNERS II QSI INVEST, L.P.   |  ELUTIA PIPE INVESTMENT, LP   |  ELUTIA INC.   |  ALPHINA THERAPEUTICS, INC.
KEVIN 
L. 
RAKIN 
EXECUTIVE OFFICER, DIRECTOR
CYVEK, INC.   |  CYOMICS, INC.   |  CYBREXA HOLDING COMPANY, LLC   |  ALPHINA THERAPEUTICS, INC.   |  AZTEK BIO, LLC   |  AZTEK BIO, INC.   |  MODIFI BIOSCIENCES, INC.   |  CAPEHAVEN HOLDING COMPANY, LLC   |  ALLYX THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2026-02-23 
2021-09-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#